© 1997 American Heart Association, Inc.
Articles |
Altered Transfer of Cholesteryl Esters and Phospholipids in Plasma From Alcohol Abusers
From the Department of Internal Medicine and Biocenter Oulu, University of Oulu, FIN-90220 Oulu, Finland.
Correspondence to Markku Savolainen, MD, PhD, Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland. E-mail markku.savolainen{at}oulu.fi
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Abstract The net mass transfer (NMT) of cholesteryl esters (CEs), triglycerides (TGs), and phospholipids (PLs) between lipoproteins was measured after incubation of fresh plasma for up to 2 hours from 18 male alcohol abusers and 17 male volunteer control subjects. In alcohol abusers the mean value of CE NMT was 3.7 nmol·mL-1·h-1 from apolipoprotein B–containing lipoproteins (apoB-containing lipoproteins) to HDL and in control subjects 8.7 nmol · mL-1 · h-1 from HDL to apoB-containing lipoproteins. The NMT of PL was higher in alcohol abusers than in control subjects (35.0 vs 11.6 nmol·mL-1·h-1 from apoB-containing lipoproteins to HDL, respectively), and plasma PL transfer protein (TP) activity was 33% higher (P<.05) in alcohol abusers than in control subjects. The lack of correlation between the NMTs and CETP and PLTP activities suggests that the NMT could more closely reflect the role of lipoprotein properties in reverse cholesterol transport in vivo, whereas in vitro activities reflect the total capacity of transfer but not its direction. The rate of CE NMT from HDL to apoB-containing lipoproteins was dependent on the VLDL TG concentration. Moreover, at low VLDL TG levels, the increased HDL cholesterol concentration in alcohol abusers reversed the direction of CE NMT. This situation could be reconstructed in the plasma of control subjects by adding autologous HDL or VLDL to mimic the lipoprotein profiles of the alcohol abusers. Addition of VLDL enhanced the CE NMT from HDL to apoB-containing lipoproteins, whereas addition of HDL had an opposite effect, and at higher HDL levels, even reversed the direction of CE NMT. In conclusion, the NMT of CE and PL in alcohol abusers differs from that in control subjects. The concentrations of HDL and VLDL seem to be the major determinants of the direction of CE NMT in alcohol abusers.
Key Words: cholesteryl ester transfer protein • reverse cholesterol transport • phospholipid transfer protein • lipoproteins • lipids
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The two lipid-transfer proteins responsible for lipid-transfer reactions between lipoprotein classes in human plasma are CETP and PLTP. CETP facilitates the transfer of CEs, TGs, and to some extent, PLs between lipoproteins.1 CETP activity in normolipidemic subjects results in an NMT of CEs from HDL to apoB-containing lipoproteins (ie, VLDL and LDL) with a reciprocal NMT of TGs to HDL.2 CETP may play a role in reverse cholesterol transport, a process in which unesterified cholesterol is removed from peripheral tissues by HDL, then esterified by LCAT, transferred to apoB-containing lipoproteins by CETP, and finally taken up in the liver by apoB/E and apoE receptors.3 On the other hand, because apoB-containing lipoproteins may carry cholesterol to peripheral tissues, the role of CETP in reverse cholesterol transport remains an open question, and CETP may not be essential for reverse cholesterol transport.3 PLTP catalyzes two thirds of the plasma PL transfer between lipoprotein classes, but it does not catalyze the transfer of neutral lipids, ie, CEs and TGs.4 PLTP could play an important role in the catabolism of TG-rich lipoproteins because it transfers the surface PLs of chylomicrons to HDL.5
Alcohol consumption is known to be associated with an elevated plasma HDL cholesterol level.6 A negative correlation between moderate alcohol consumption and coronary heart disease has also been observed.7 The mechanisms by which alcohol elevates HDL cholesterol remain unclear, but at least part of it may be mediated by a reduction in plasma CETP activity8 . Because alcohol reduces plasma CETP activity and mass, it might inhibit reverse cholesterol transport.
The higher HDL concentration in alcohol drinkers may influence lipid-transfer reactions and reverse cholesterol transport. Several studies indicate that lipoprotein substrate concentrations and their lipid contents influence lipid-transfer reactions. For example, supplementation of normolipidemic plasma with autologous VLDL increases the CE NMT from HDL to VLDL,11 whereas an increase in HDL concentration decreases CE transfer.12 13 Studies of HDL enriched with phosphatidylcholine14 15 have confirmed an increase in CE transfer, most probably due to increased binding of CETP to HDL. Furthermore, unesterified cholesterol enrichment of plasma lipoproteins stimulates CE transfer from HDL to VLDL and reciprocal transfer of TGs from VLDL to HDL.16
The purpose of this study was to elucidate the effect of alcohol on reverse cholesterol transport by investigating the NMT of CEs and other lipids as well as the effects of lipoprotein concentrations on transfer reactions.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Subjects
The study was carried out in 22 male alcohol abusers who had been referred by their general practitioners and were admitted as inpatients to the Alcoholism Treatment Unit in Oulu for withdrawal therapy. This unit treats ambulatory patients seeking assistance for terminating their dependence on alcohol and having no signs or symptoms of other diseases. Patients who were acutely ill with alcohol-related or other diseases were referred to other clinics. All 22 alcohol drinkers had been drinking daily for at least 1 week before admission. The subjects were included if their nutritional status was sound and they did not have any clinical signs of kidney or heart dysfunction or severe liver damage, such as spiders, jaundice, or hepatomegaly. Four of the 22 subjects were excluded on the basis of highly elevated liver enzymes (exclusion criteria were alanine aminotransferase values >160 U/L, alkaline phosphatase >750 U/L, or gamma glutamyltransferase >1200 U/L), leaving a total of 18 study subjects.
Through an extensive interview by a trained physician, alcohol intake among both control and alcohol-abusing subjects was assessed: the amount of beer, wine, and strong alcoholic beverages (distilled) consumed during the previous 2 weeks was ascertained and recorded. Alcohol intake was calculated and expressed in grams of pure alcohol per day. Information was also obtained about smoking habits (pipe, cigar, and cigarettes), drug abuse, and past medical history. None of the alcohol abusers were skid row alcoholics or dependent on narcotics. None of the alcohol abusers or control subjects used prescription drugs or had diseases that might influence lipid metabolism.
Seventeen healthy men volunteered as control subjects. They were interviewed in the same manner as the alcohol abusers and had similar inclusion/exclusion criteria, except for alcohol drinking. Six of these men were teetotalers and the others reported occasional, moderate alcohol intake. The study was approved by the Ethics Committee of the University of Oulu.
Experimental Design
Venous blood samples were drawn into EDTA-containing evacuated
tubes after an overnight fast from both the alcohol abusers and control
subjects. Blood samples from the alcohol abusers were taken on the
first day after admission into the treatment unit. The tubes were
immediately chilled on ice and centrifuged at 2°C to separate
the plasma. The plasma was kept on ice and the experiments immediately
started after plasma separation. The samples for CETP and PLTP activity
were stored at -70°C.
Cholesterol Esterification and Lipid NMT
Reactions
Five samples of each subject's plasma were incubated at 37°C
for 0, 0.5, 1, 1.5, and 2 hours according to the method of Fielding et
al.17 All incubations were performed using fresh plasma
within 2 hours after venipuncture. After incubation,
aliquots of plasma were mixed with a one-tenth volume of 2 mol/L
MgCl2 and dextran sulfate (1:1, vol/vol) to
precipitate the apoB-containing lipoproteins.18 The
supernatant was then separated and kept on ice until measurements of
total and free cholesterol, TGs, and PLs were made by
enzymatic colorimetric methods. The CE concentrations
were calculated as the difference between total and free
cholesterol concentrations.
The NMT of CEs was calculated as the rate of change in CEs in apoB-containing lipoproteins and cholesterol esterification as the rate of change in total plasma CEs. In addition, the NMTs of TGs and PLs were measured in 9 alcohol abusers and 10 control subjects and calculated as the rate of change in TGs or PLs in apoB-containing lipoproteins. Thus, the NMT of lipids from HDL to VLDL and LDL has a positive sign and the NMT from VLDL and LDL to HDL a negative sign.
The CV was 0.8% for total plasma CEs and 1.5% for apoB-containing
lipoprotein CEs. CVs for CE NMT were 23.8% for very high negative
transfer rates (<-100 nmol ·
mL-1 · h-1),
36.8% for low negative esterification rates (-20 to -60 nmol
· mL-1 ·
h-1), 30.0% for low positive transfer rates
(20 to 60 nmol · mL-1 ·
h-1), and 35.2% for high positive transfer
rates (
60 nmol · mL-1 ·
h-1). For PL and TG NMTs, the CVs were similar
to those of CE NMT. For cholesterol esterification, the CVs
were 13.3% for high rates of esterification (80 nmol ·
mL-1 · h-1)
and 16.5% for medium rates of esterification (20 to 80 nmol ·
mL-1 · h-1).
The NMT analysis was performed twice on 2 different days for
three control plasma samples. The SD for these measurements was 8.7
nmol · mL-1 ·
h-1 for CE NMT, 26.1 nmol ·
mL-1 · h-1 for
TG NMT, 10.8 nmol · mL-1 ·
h-1 for PL NMT, and 6.1 nmol ·
mL-1 · h-1 for
cholesterol esterification. In some experiments, LCAT
activity was inhibited by adding 1.5 mmol/L iodoacetic acid
prior to incubation. No major effect of LCAT inhibition on lipid NMTs
was seen in either the alcohol abusers or control subjects.
Experiments With Altered HDL Concentrations
The effect of HDL cholesterol concentration on NMT
reactions was studied by raising the HDL cholesterol
concentration by a factor of 2 or 3 with respect to the original level
in the plasma. The HDL fraction (d=1.090 to 1.21
g/mL) was isolated by ultracentrifugation from
130 mL of a control subject's plasma. After dialysis against 0.15
mol/L NaCl–0.01% EDTA, pH 7.4, at 4°C for at least 3 hours,
the cholesterol content in HDL was measured, and an aliquot
of the HDL fraction was added to the same subject's plasma sample to
increase its HDL cholesterol level twofold or threefold.
The addition of HDL to the plasma diluted it by as much as 25%. The
possible effect of dilution on NMTs was tested by adding 0.15
mol/L NaCl–0.01% EDTA, pH 7.4, to the plasma in a volume ratio
of 1:3. In the plasma from these three control subjects, no change in
NMTs was observed (data not shown).
Experiments With Altered VLDL Concentrations
The effect of VLDL concentration on the NMT of lipids was
studied by removing VLDL from the plasma by
ultracentrifugation or by raising the VLDL
cholesterol concentration twofold or threefold with respect
to the original plasma VLDL cholesterol level. The VLDL
fraction (d<1.006 g/mL) was isolated by
ultracentrifugation and added to the same subject's
plasma sample to increase its VLDL concentration by a factor of 2 or 3.
Experiments with VLDL-free plasma obtained from the VLDL isolation
procedure were also performed for the same three control subjects.
Because addition of VLDL to plasma caused some dilution, we added the
same volume of 0.15 mol/L NaCl–0.01% EDTA, pH 7.4, to the
original plasma as that of VLDL. VLDL-free plasma was also diluted in
the same manner, and therefore in all experiments with VLDL addition,
the concentrations of lipoproteins other than VLDL remained the
same.
Chemical Analyses
Total plasma cholesterol, free
cholesterol, TG, and PL concentrations were determined by
enzymatic colorimetric methods using a Kone specific
selective chemistry analyzer (Kone Oy) and kits from
Boehringer Diagnostica (catalogue Nos. 236691,
310328, and 701912) and Wako Chemicals (No. 990-54009), respectively.
CVs for the determination of plasma total cholesterol, free
cholesterol, TGs, and PLs were 2.1±1.3%, 2.4±1.3%,
5.3±3.1%, and 0.9±0.6%, respectively.
To analyze VLDL and LDL concentrations separately, 1 mL of the VLDL-free fraction isolated by ultracentrifugation (as described above) was mixed with 25 µL of 2.8% (wt/vol) heparin and 25 µL of 2 mol/L MnCl2 and centrifuged at 1000g and 4°C for 30 minutes. Aliquots of the supernatant were taken for lipid analysis. The LDL lipid concentrations were calculated by subtracting the cholesterol concentration in HDL from that in the VLDL-free fraction, and the VLDL lipid concentrations were analyzed in the VLDL fraction.
Determination of CETP Activity
CETP activity was determined in (VLDL+LDL)-free plasma by a
modification of the method of Groener et al19 as described
earlier8 9 10 by detecting the exchange of radioactive CEs
between labeled LDL and unlabeled HDL, both isolated from control
subjects. This method reflects the CETP protein
concentration.9
Determination of PLTP Activity
PLTP activity was determined with radiolabeled
phosphatidylcholine–containing liposomes as described
earlier20 using 10 µmol of egg phosphatidylcholine
(Sigma), 1 µCi of [14C]dipalmitoylphosphatidylcholine
(Amersham), and 20 nmol BHT (Sigma). The assays were performed as
described earlier21 in a volume of 400 µL containing
HDL3 (250 µg of protein); liposomes (150 nmol of
[14C]phosphatidylcholine-labeled liposomes); buffer
containing 150 mmol/L NaCl, 10 mmol/L Tris, and
1 mmol/L EDTA, pH 7.4; and a plasma sample (6.0 µL
diluted 1:10 in buffer). "Blank" tubes (with all of the
aforementioned constituents except the plasma sample), "control"
tubes (containing plasma from a healthy volunteer), and "total"
tubes (without precipitation of liposomes) were included in each
series. The tubes were incubated in a water bath at 37°C for 1.5
hours. The reaction was stopped by adding 300 µL of 500
mmol/L NaCl, 215 mmol/L MnCl2, and 140 U
heparin. The tubes were vortexed and, after allowing them to stand for
10 minutes at room temperature, centrifuged for 10 minutes at
13 000 rpm. Aliquots of 500 µL were taken from the supernatant for
determination of radioactivity. The sample volume and incubation time
were chosen so that they were within the linear range of the volume and
incubation time curves (the reaction was linear from 0.5 to 2 hours and
from 0.1 to 1.0 µL in both plasma and lipoprotein-free plasma from
the alcohol abusers and control subjects).
Statistical Methods
The results are given as mean±SEM. Differences between means
were calculated with Student's t test or ANOVA using the
spss program. The Levene test was used to explore the distribution of
CE NMT data between the alcohol abusers and control subjects. The rate
of cholesterol esterification and NMTs were estimated by
linear regression. Because total plasma cholesterol
concentrations were assumed to remain constant during these short
incubations, total cholesterol values were used at each
time point to correct the other lipid values for potential changes
caused by evaporation, condensation, or drift in lipid determinations.
At any time point, the total cholesterol concentration was
within 97.5% to 102.5% of the mean during the incubation.
For analyzing the effects of lipoprotein concentrations on NMT rates, we used the natural logarithmic of the reciprocal of the variance of the regression coefficient to weight the variables and minimize the effects of the less exact determinations of NMT. These results did not differ from those calculated using unweighted NMT values. The differences between regression lines were calculated using the Confidence Interval Analysis program (based on the methods of Gardner and Altman).22
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Clinical Characteristics and Lipid Values
Clinical characteristics of the alcohol abusers and control subjects are shown in Table 1
. The mean
daily alcohol consumption was 189 g in the alcohol abuser group
and 7 g in the control group. Seventy-four percent of alcohol
abusers and 6% of control subjects were smokers (data not shown). Mean
age and body mass index were almost identical between the alcohol
abusers and control subjects. Liver enzyme levels were higher in the
alcohol abusers (Table 1). The concentrations of HDL
cholesterol, HDL free cholesterol, HDL CEs, and
HDL PLs, as well as total plasma TGs, apoB-containing lipoprotein TGs,
and total PLs, were significantly higher in the alcohol abusers than
the control subjects (Table 2).
|
|
Cholesterol Esterification
The rate of cholesterol esterification in plasma,
calculated as the rate of change in plasma CE concentration, was
somewhat but not significantly higher in the alcohol abusers than
control subjects (53.9±7.3 nmol ·
mL-1 · h-1
versus 39.4±5.6 nmol · mL-1 ·
h-1, respectively, P=.13; Fig 1).
|
NMT of CEs Between Lipoproteins
The mean value of CE transfer was -3.7 nmol ·
mL-1 · h-1
(ie, from apoB-containing lipoproteins to HDL) in the alcohol abusers
and 8.7 nmol · mL-1 ·
h-1 (ie, from HDL to apoB-containing
lipoproteins) in the control subjects (P=NS; Fig 1
). Both
groups included individuals who had values for CE transfer from HDL to
apoB-containing lipoproteins and individuals whose values were in the
opposite direction (n=11 and 7, respectively, in the alcohol abusers
versus 12 and 5, respectively, in control subjects). However, the range
of CE transfer values was larger in the alcohol abusers (from -141.7
to 82.4 nmol · mL-1 ·
h-1) than in control subjects (from -65.9 to
57.4 nmol · mL-1 ·
h-1). The variances were statistically
significantly different between the alcohol abusers and control
subjects when tested with the Levene test (P<.001). The
amount of alcohol consumed seemed to have no effect on CE NMT among the
alcohol abusers or control subjects (Fig 2).
|
NMT of TGs Between Lipoproteins
Alcohol abuse did not influence the TG NMT. The rate and direction
of TG NMT were similar in the alcohol abusers and control subjects
(mean value of -20.1 versus -19.6 nmol ·
mL-1 · h-1
from apoB-containing lipoproteins to HDL, respectively; Fig 1). During
incubation of the plasma, lipolysis of TG-rich particles could liberate
free glycerol, which would appear in the supernatant after
precipitation and lead to erroneously high NMT rates from
apoB-containing lipoproteins to HDL. To control for this possibility,
we measured HDL TG concentration in two samples after removal of free
glycerol by dialysis. The rate of lipolysis (ie, the decrease in TG
concentration in the total plasma sample during incubation) was
negligible compared with the TG NMT (calculated as the rate of change
in TGs in apoB-containing lipoproteins).
NMT of PLs Between Lipoproteins
Alcohol abuse had a marked impact on the PL NMT. The direction of
PL NMT in both the alcohol abusers and control subjects was from
apoB-containing lipoproteins to HDL, but the NMT rate in the alcohol
abusers was almost fourfold than that in the control subjects (mean
value of -39.2 versus -11.6 nmol ·
mL-1 · h-1,
respectively; Fig 1). The PL NMT was correlated with
cholesterol esterification in the alcohol abusers
(r=.66, P=.05) but not in the control subjects
(data not shown). Enzymatic or nonenzymatic degradation of PLs
(phosphatidylcholine, lysophosphatidylcholine, or sphingomyelin) during
incubation could lead to the appearance of free choline in the
supernatant after the dextran-sulfate precipitation step, and the
presence of free choline would result in falsely elevated levels of HDL
PLs in the choline oxidase–based determination of PLs and in an
apparent NMT of PLs from apoB-containing lipoproteins to HDL. This
possibility was ruled out by dialysis of two samples, which showed that
free choline was not detected after incubation and that PL degradation
therefore had no significant effect on the determination of PL NMT.
CETP and PLTP Activities and Their Correlations With Corresponding
Lipid NMTs
We made a novel observation on PLTP activity in alcohol abusers.
The alcohol abusers had a 33% higher PLTP activity than the control
subjects (P<.05) in this sample of 18 alcohol abusers and
17 control subjects (Table 3). We also
determined the PLTP activity in 17 alcohol abusers and 19 control
subjects from a previous study,10 and those results
confirmed the higher PLTP activity in alcohol abusers (26% higher than
that of control subjects, P<.05). In the total series of 35
alcohol abusers and 36 control subjects from both studies combined,
PLTP activity was 29% higher in alcohol abusers than in control
subjects (P=.001). However, no significant correlation was
observed between PLTP activity and the NMT of PLs, although a trend was
observed in control subjects (r=-.61, P=.062 for
control subjects and r=-.38, P=.31 for alcohol
abusers). CETP activity was 31% lower in the alcohol abusers than in
the control subjects (P<.001; Table 3), but no significant
correlation was observed between CETP activity and CE NMT, although a
trend was observed in the alcohol abusers (r=.21,
P=.42 for control subjects and r=.42,
P=.08 for the alcohol abusers).
|
Correlations Between Lipids and Lipid NMTs
To investigate the role of major alcohol-induced lipoprotein
changes in the lipid NMT reactions of the alcohol abusers, we plotted
HDL cholesterol and VLDL TGs against the lipid NMTs and
cholesterol esterification. A strong, negative correlation
was found between HDL cholesterol and CE NMT as well as
between HDL cholesterol and cholesterol
esterification in the alcohol abusers (r=-.667,
P<.01 and r=-.736, P<.001,
respectively; Table 4), suggesting that
higher HDL cholesterol concentrations could inhibit
cholesterol esterification and the NMT of CEs to
apoB-containing lipoproteins. A negative correlation was also seen
between HDL cholesterol and PL NMT in the alcohol abusers
(r=-.767, P<.05), whereas the control subjects
showed an opposite trend (Table 4). VLDL TGs had a strong, positive
correlation with the CE NMT and cholesterol esterification
in the alcohol abusers (r=.574, P<.05 and
r=.657, P<.01, respectively) and with
cholesterol esterification in the control subjects
(r=.567, P<.05) (Table 4), indicating the key
role of VLDL TGs in determining the direction of CE NMT.
|
We used linear regression to evaluate the impact of key lipid parameters on lipid NMT and cholesterol esterification. HDL cholesterol was the sole significant predictor of CE NMT and cholesterol esterification in the alcohol abusers, accounting for 44% of the CE NMT and 54% of cholesterol esterification. HDL cholesterol and VLDL TGs together explained 95% of the PL NMT in the alcohol abusers, although HDL cholesterol was a more important predictor for PL NMT. Interestingly, VLDL TGs accounted for 35% of the variation in cholesterol esterification in the control subjects, but the lipid NMTs were not explained by the key lipid parameters in the control subjects.
Effect of HDL Concentrations on Lipid NMTs
The results shown in Table 4 point to the role of HDL
cholesterol as the determinant of the rate or direction of
lipid NMT. Therefore, we further studied the role of ethanol-induced
HDL changes by increasing the number of HDL particles in the plasma
samples of control subjects (Fig 3). Our
aim was to test whether the effect of high HDL levels on lipid NMTs
observed in the plasma from alcohol abusers could also be reproduced in
the control subjects' plasma by increasing its HDL level. Addition of
an isolated HDL fraction into control plasma before incubation at a
twofold or threefold higher concentration reversed the direction of CE
NMT in the control subjects, so that the direction of NMT was from
apoB-containing lipoproteins to HDL (P<.01) under
conditions of increased HDL, similar to what we observed in the alcohol
abusers (Fig 3A). Cholesterol esterification and the TG and
PL NMTs were not significantly affected by the increased HDL
concentration (Fig 3A and 3B).
|
Because the HDL concentration seemed to be the most important
determinant of CE NMT, we plotted the HDL concentration–predicted CE
NMT against the observed NMT. The equation calculated from this HDL
increase–affected reverse in the direction of CE NMT (Fig 3) was used
to calculate the predicted values. Fig 4
shows how the predicted CE NMTs were
correlated with those observed. The correlation coefficients between
predicted and observed NMTs were .67 (P<.01) for the
alcohol abusers, .11 (P=.67) for control subjects, and .53
(P<.001) for both the alcohol abuser and control groups
together.
|
Effect of VLDL Concentration
An increase in VLDL TGs is another ethanol-induced
disturbance in lipoproteins. An approach similar to that
described for HDL was adopted to investigate the effect of VLDL
concentration on lipid NMT reactions (Fig 5). The CE (Fig 5A) and TG (Fig 5B) NMT
rates in VLDL-depleted plasma were found to be almost undetectable and
cholesterol esterification was slower than in plasma,
whereas the PL NMT (Fig 5A) was not affected by changes in VLDL
concentrations. Twofold or threefold higher concentrations of VLDL
further increased the CE NMT (Fig 5A) from HDL to apoB-containing
lipoproteins (P<.05) but slowed the cholesterol
esterification rate (Fig 5B), indicating the role of VLDL in
determining the rate and direction of CE NMT.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Because the low plasma CETP activity in alcohol drinkers9 might reduce the rate of reverse cholesterol transport, we studied the NMTs of CEs, TGs, and PLs between lipoproteins in alcohol abusers. The present study shows that alcohol drinking may affect the CE NMT through its effect on VLDL and HDL concentrations. Furthermore, the alcohol abusers had a higher rate of PL NMT than the control subjects.
The mean value of CE NMT in the present control subjects is in accordance with the postulated CE transfer step of reverse cholesterol transport and with previous NMT studies,2 11 although the NMT of CEs toward HDL has also been reported.23 Previously, van Tol et al24 described induction of the NMT of CEs and TGs by moderate wine consumption with dinner. The difference between their results and our present findings may be due to the amount of alcohol consumed, since moderate consumption of alcohol by social drinkers may have a more marked effect on VLDL than on HDL and the direction of NMT may be therefore from HDL to apoB-containing lipoproteins.
The correlations observed between HDL cholesterol or VLDL TGs and CE NMT or cholesterol esterification point to the role of HDL and VLDL concentrations as determinants of the CE NMT process in alcohol abusers. The importance of VLDL in CE transfer has been previously reported,11 25 and an effect of HDL has also been described for normal subjects.12 13 We added autologous lipoprotein fractions to the plasma sample of the control subjects to mimic the lipoprotein profiles seen in the alcohol abusers. The addition of VLDL enhanced the CE NMT from HDL to apoB-containing lipoproteins, whereas addition of HDL had an opposite effect, and higher HDL levels even reversed the direction of CE NMT, which means that control subjects with increased HDL concentrations mimicked the alcohol abusers. Our results indicate that lipoprotein concentrations play a key role in the regulation of CE NMT, although alcohol-induced changes in lipoprotein composition, ie, the higher TG content in apoB-containing lipoproteins or higher HDL CE content,26 may also affect lipid NMTs, a question that is presently being studied in our laboratory. Moreover, the alcohol-induced increase in HDL may be a self-promoting process, ie, the higher the HDL cholesterol level, the more CEs are transferred from apoB-containing lipoproteins to HDL. Thus, CETP may be less important than lipoprotein concentrations per se, and it seems that the low concentration of CETP may not be rate limiting in alcohol abusers despite their high VLDL TG levels. This finding is in contrast with previous results, which showed that a normal CETP level may not be sufficient in the presence of a very high VLDL TG concentration.11
Our study is the first in which PL NMT has been determined in both alcohol abusers and control subjects. In the present study, the PL NMT was almost fourfold higher in the alcohol abusers than in the control subjects, and the NMT rate was surprisingly high in both groups. Our observations agree with recent studies in which a PL NMT rate of 27.2 nmol · mL-1 · h-1 was demonstrated in healthy volunteers27 and a high rate of PL exchange was observed in an isotopic assay.28 In accordance with a recent study, in which Lagrost et al29 observed a reduction in PLTP activity by alcohol withdrawal, our present study demonstrates for the first time that alcohol abusers have higher plasma PLTP activity than do control subjects. Moreover, the NMT rate of PLs from apoB-containing lipoproteins to HDL was increased, especially in the alcohol abusers with a high NMT rate of CEs in the same direction. The increased CE content in the core of HDL particles due to the increased NMT would require a larger surface area, which in turn could create a demand for surface lipids, including PLs. In alcohol abusers with higher cholesterol esterification rates, more (unesterified) cholesterol may move from the surface to the core during esterification, further increasing the requirement for surface components to be transferred from other lipoprotein particles. The results suggest that more attention should be given to the role of PLs to reveal whether they are nonparticipants or have a more active role in lipid metabolism than has been previously assumed.
Severe liver damage might affect the lipid NMTs and cholesterol esterification in alcohol abusers.30 31 In this study, the cholesterol esterification rate was higher in alcohol abusers than in the control subjects, indicating that our exclusion of alcohol abusers with liver failure was successful. The higher LCAT activity in alcohol abusers might be due to induction of LCAT synthesis in the liver.32 In accordance with a previous study,33 a strong correlation was found between cholesterol esterification and CE NMT. Because both LCAT and CETP are present in the plasma in vivo, inhibition of LCAT activity in the NMT analysis could remove an essential step in reverse cholesterol transport, and since the aim of this study was to investigate the events of reverse cholesterol transport in an experimental setting resembling the in vivo situation as closely as possible, we did not inhibit LCAT activity.17 It must be borne in mind, however, that the first (supply of premature HDL particles with low CE content) and the last (uptake of HDL particles or selective uptake of CEs) steps of reverse cholesterol transport were absent even in these ex vivo incubation experiments, although experiments of this kind are often referred to as in vivo experiments. More complicated methods, such as the one described by Mindham et al,34 35 may be required to completely reconstruct reverse cholesterol transport in an experimental setting.
In the present study, it was not possible to evaluate the roles of VLDL and LDL separately in the NMT process, since the MgCl2–dextran sulfate precipitation used in this study does not separate VLDL from LDL. Previous studies with separation of LDL from VLDL revealed an NMT of CEs from HDL and LDL to VLDL and a reciprocal NMT of TGs.25 36 . Because VLDL appears to be the major acceptor of CEs and donor of TGs, the effect of pooled VLDL and LDL on the results of the present study may not be significant. Further studies may be required to confirm this, however, since ethanol affects the binding of CETP to various lipoprotein fractions by increasing the proportion of plasma CETP bound to VLDL, at least in experiments with perfused rabbit livers.39
The previously described lack of correlation between CETP activity and CE NMT may be due to the basic differences between the two methods widely used for evaluation of CETP function.23 11 CETP activity is determined by measuring the exchange of radiolabeled CEs between an excess of exogenous lipoproteins,19 which gives an accurate estimate of CETP protein concentration.9 The ex vivo NMT analysis is performed under more physiological conditions with endogenous lipoproteins, and in contrast to the CETP activity assay, also gives the direction of transfer. However, in spite of these methodological reservations, the CE NMT measured in the ex vivo plasma samples could more accurately reflect the role of lipoprotein particles in reverse cholesterol transport than does CETP activity, which reflects only the total capacity of transfer but not its direction. Similar methods are used for the determination of PLTP activity20 and PL NMT, and no correlation was observed between the two methods of PL transfer. Therefore, with the same kind of methodological reservations as for CETP, the two methods can be used for the determination of PL transfer activity.
In conclusion, transfer of CEs and PLs is altered in the alcohol abuser. Plasma PLTP activity is higher and CETP activity lower in alcohol abusers than in control subjects, but neither CETP activity nor PLTP activity are correlated with their corresponding lipid NMTs. The rate and direction of CE transfer may be predominantly due to alcohol-induced changes in HDL and VLDL concentrations rather than to the effects of alcohol on CETP itself.
|
Selected Abbreviations and Acronyms |
|---|
|
|
Acknowledgments |
|---|
This work was supported by the Finnish Foundation of Alcohol Studies (to M.J.L., M.J.S.), the Finnish Foundation for Cardiovascular Research (to M.J.L., M.L.H., M.J.S.), the Academy of Finland (all authors), and the Deaconess Institute of Oulu (M.J.L.). We wish to thank Drs Riitta Heikkilä and Marita Paassilta for their help in collecting the blood samples. We are also very grateful to the staff of the Kiviharju Alcoholism Treatment Unit for their cooperation. The skillful technical assistance of Saija Kortetjärvi and Eila Saarikoski is greatly appreciated.
Received January 3, 1997; accepted May 30, 1997.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Hesler CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW. Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem. 1988;263:5020-5023.
2.
Chajek T, Fielding CJ. Isolation and
characterization of a human serum cholesteryl ester transfer
protein. Proc Natl Acad Sci U S A. 1978;75:3445-3449.
3. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.[Abstract]
4.
Tall AR, Abreu E, Shuman J. Separation of a
plasma phospholipid transfer protein from cholesterol
ester/phospholipid exchange protein. J Biol
Chem. 1983;258:2174-2180.
5. Tall AR. Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma high density lipoproteins in rat. J Lipid Res. 1980;21:354-363.[Abstract]
6. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. Alcohol and blood lipids: the cooperative lipoprotein phenotyping study. Lancet. 1977;2:153-155.[Medline] [Order article via Infotrieve]
7. Rimm EB, Giovanucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and coronary disease in man. Lancet. 1991;338:464-468.[Medline] [Order article via Infotrieve]
8. Savolainen MJ, Hannuksela M, Seppänen S, Kervinen K, Kesäniemi YA. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest. 1990;20:593-599.[Medline] [Order article via Infotrieve]
9. Hannuksela M, Marcel YL, Kesäniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 1992;33:737-744.[Abstract]
10. Hannuksela ML, Liinamaa MJ, Kesäniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110:35-44.[Medline] [Order article via Infotrieve]
11. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism for plasma cholesteryl ester transfer in hyperlipidemia. J Clin Invest. 1991:88:2059-2066.
12.
Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V,
Lallemant C, Gambert P. Influence of plasma cholesteryl ester
transfer activity on the LDL and HDL distribution profiles in
normolipidemic subjects. Arterioscler Thromb. 1993;13:815-825.
13.
Tollefson JH, Liu A, Albers JJ. Regulation of
plasma lipid transfer by the high-density lipoproteins.
Am J Physiol. 1988;255:E894–E902.
14.
Sammett D, Tall AR. Mechanism of enhancement of
cholesteryl ester transfer protein activity by lipolysis.
J Biol Chem. 1985;260:6687-6697.
15. Tall AR, Granot E, Brocia RE, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma: role of cholesteryl ester transfer protein. J Clin Invest. 1987;79:1217-1225.
16.
Morton RE. Free cholesterol is a
potent regulator of lipid transfer protein function.
J Biol Chem. 1988;263:12235-12241.
17. Fielding PE, Jackson EM, Fielding CJ. Chronic dietary fat and cholesterol inhibit the normal postprandial stimulation of plasma cholesterol metabolism. J Lipid Res. 1989;30:1211-1217.[Abstract]
18. Ogawa Y, Fielding CJ. Assay of cholesterol ester transfer activity and purification of a cholesteryl ester transfer protein. Methods Enzymol. 1985;111:275-285.
19.
Groener JEM, Pelton RW, Kostner GM. Improved
estimation of cholesterol ester transfer/exchange activity
in serum or plasma. Clin Chem. 1986;32:283-286.
20. Damen J, Regts J, Scherphof G. Transfer of [14C]phosphatidylcholine between liposomes and human plasma high density lipoprotein: partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim Biophys Acta. 1982;712:444-452.[Medline] [Order article via Infotrieve]
21. Pussinen P, Jauhiainen M, Metso J, Tyynelä J, Ehnholm C. Pig plasma phospholipid transfer protein facilitates HDL interconversion. J Lipid Res. 1995;36:975-985.[Abstract]
22. Gardner MJ, Altman DG. Statistics With Confidence. London, England: British Medical Journal; 1989.
23.
Van Tol A, Scheek LM, Groener JEM. Net mass
transfer of cholesteryl esters from low density lipoproteins to high
density lipoproteins in plasma from normolipidemic subjects.
Arterioscler Thromb. 1991;11:55-63.
24. Van Tol A, Groener JEM, Scheek LM, van Gent T, Veenstra J, van de Pol H, Hendrijks HFL, Schaafsma G. Induction of net mass transfer reactions in plasma by wine consumption with dinner. Eur J Clin Invest. 1995;25:390-395.[Medline] [Order article via Infotrieve]
25. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects of cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest. 1989;83:2018-2024.
26. Liinamaa MJ, Kervinen K, Hannuksela ML, Kesäniemi YA, Savolainen MJ. Effect of apolipoprotein E in the alcohol abusers. Alcohol Clin Exp Res. 1997;21:606-612.[Medline] [Order article via Infotrieve]
27. Cheung MC, Wolfbauer G, Albers JJ. Plasma phospholipid net mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters. Biochim Biophys Acta. 1996;1303:103-110.[Medline] [Order article via Infotrieve]
28. Elchebly M, Pulcini T, Porokhov B, Berthezene F, Ponsin G. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur J Clin Invest. 1996;26:216-223.[Medline] [Order article via Infotrieve]
29.
Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V,
Artur Y, Paille F, Gambert P, Lallemant C. Opposite effects of
cholesteryl ester transfer protein and phospholipid transfer protein on
the size distribution of plasma high density lipoproteins:
physiological role in alcoholic patients.
J Biol Chem. 1996;271:19058-19065.
30. Tahara D, Nakanishi T, Akazawa S, Yamaguchi Y, Yamamoto H, Akashi M, Chikuba N, Okuno S, Maeda Y, Kusumoto Y, Nagataki S. Lecithin:cholesterol acyltransferase and lipid transfer protein activities in liver disease. Metabolism. 1993;42:19-23.[Medline] [Order article via Infotrieve]
31. Horton RC, Owen JS. LCAT activity is a prognostic liver function test. Lancet. 1990;336:249-250.
32. Lieber CS. The metabolism of alcohol. Sci Am. 1976;234:25-33.
33.
Murakami T, Michelagnoli S, Longhi R, Gianfranceschi G,
Pazzucconi F, Calabresi L, Sirtori CS, Franceschini G.
Triglycerides are major determinants of
cholesterol esterification/transfer and HDL remodeling in
human plasma. Arterioscler Thromb Vasc Biol. 1995;15:1819-1828.
34. Mindham MA, Mayes PA. Application of organ perfusion to the study of reverse cholesterol transport. Ann N Y Acad Sci. 1995;748:240-263.[Medline] [Order article via Infotrieve]
35. Mindham MA, Mayes PA. Application of simultaneous spleen and liver perfusion to the study of reverse cholesterol transport. Biochem J. 1994;302:207-213.
36. Liu XQ, Bagdade JD. Neutral lipid mass transfer among lipoproteins in plasma from normolipidemic subjects is not an equimolar heteroexchange. J Lipid Res. 1995;36:2574-2579.[Abstract]
37. Sniderman A, Teng B, Vezina C, Marcel YL. Cholesteryl ester exchange between plasma high and low density lipoproteins mediated by a plasma protein factor. Atherosclerosis. 1978;31:327-333.[Medline] [Order article via Infotrieve]
38. Barter PJ, Gorjatschko L, Calvert GD. Net mass transfer of esterified cholesterol from human low density lipoproteins to very low density lipoproteins incubated in vitro. Biochim Biophys Acta. 1980;619:436-439.[Medline] [Order article via Infotrieve]
39.
Hannuksela ML, Rantala M, Kesäniemi YA,
Savolainen MJ. Ethanol-induced redistribution of cholesteryl
ester transfer protein (CETP) between lipoproteins.
Arterioscler Thromb Vasc Biol. 1996;16:213-221.
This article has been cited by other articles:
 |
|
 |
|
  C. Schafer, A. Parlesak, J. Eckoldt, C. Bode, J. C. Bode, W. Marz, and K. Winkler Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers J. Lipid Res., July 1, 2007; 48(7): 1550 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. LIINAMAA, M. L. HANNUKSELA, M. E. RAMET, and M. J. SAVOLAINEN DEFECTIVE GLYCOSYLATION OF CHOLESTERYL ESTER TRANSFER PROTEIN IN PLASMA FROM ALCOHOL ABUSERS Alcohol Alcohol., January 1, 2006; 41(1): 18 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T Salonen Liver damage and protective effect of high density lipoprotein cholesterol BMJ, November 8, 2003; 327(7423): 1082 - 1083. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Murdoch, S. E. Kahn, J. J. Albers, J. D. Brunzell, and J. Q. Purnell PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity J. Lipid Res., September 1, 2003; 44(9): 1705 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Corella, K. Tucker, C. Lahoz, O. Coltell, L A. Cupples, P. W. Wilson, E. J Schaefer, and J. M Ordovas Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study Am. J. Clinical Nutrition, April 1, 2001; 73(4): 736 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oka, T. Kujiraoka, M. Ito, T. Egashira, S. Takahashi, M. N. Nanjee, N. E. Miller, J. Metso, V. M. Olkkonen, C. Ehnholm, et al. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive J. Lipid Res., October 1, 2000; 41(10): 1651 - 1657. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Oka, T. Kujiraoka, M. Ito, M. Nagano, M. Ishihara, T. Iwasaki, T. Egashira, N. E. Miller, and H. Hattori Measurement of Human Plasma Phospholipid Transfer Protein by Sandwich ELISA Clin. Chem., September 1, 2000; 46(9): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||